Most immature T-ALLs express Ra-IL3 (CD123): possible target for DT-IL3 therapy
Open Access
- 10 August 2006
- journal article
- letter
- Published by Springer Nature in Leukemia
- Vol. 20 (10) , 1908-1910
- https://doi.org/10.1038/sj.leu.2404349
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Diphtheria toxin fused to variant human interleukin-3 induces cytotoxicity of blasts from patients with acute myeloid leukemia according to the level of interleukin-3 receptor expressionBlood, 2005
- HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL)Blood, 2005
- Impact of TCR status and genotype on outcome in adult T-cell acute lymphoblastic leukemia: a LALA-94 studyBlood, 2005
- Age-related phenotypic and oncogenic differences in T-cell acute lymphoblastic leukemias may reflect thymic atrophyBlood, 2004
- Interleukin-3 receptor in acute leukemiaLeukemia, 2003
- Analysis of TCR, pTα, and RAG-1 in T-acute lymphoblastic leukemias improves understanding of early human T-lymphoid lineage commitmentBlood, 2003
- Elevated expression of IL-3Rα in acute myelogenous leukemia is associated with enhanced blast proliferation, increased cellularity, and poor prognosisBlood, 2002
- Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemiaCancer Cell, 2002